Federal Register / Vol. 75, No. 90 / Tuesday, May 11, 2010 / Notices 26267 

Purpose of the Meeting 

This meeting will bring basic research 

scientists working on models of 

autoimmune disease relevant to lupus 

together with clinicians treating lupus 

patients. There are numerous mouse 

models of lupus, but their relevance to 

the actual disease is still a subject for 

debate. Thus it is the purpose of this 

meeting to have participants discuss 

similarities, as well as differences, in 

mouse models with respect to the 

disease with the clinicians who actually 

treat patients. In addition, input is 

encouraged from clinical attendees 

regarding what markers in an animal 

model would be most important for 

monitoring the disease and assessing 

the effectiveness of treatment. It is 

hoped that one consequence of this 

meeting might be some consensus as to 

what is most important in any animal 

model and what animal models might 

be most useful in developing new 

markers and treatments for the disease. 

For more information, including the 

agenda and registration for this 

conference, please see http:// 

web.ncifcrf.gov/events/SystemicLupus/ 

default.asp. 

Contacts: 

Howard Young: Senior Investigator, 

NCI, NIH; 301–846–5700; 

younghow@mail.nih.gov. 

Silvia Bolland: Senior Investigator, 

NIAID, NIH; 301–443–3158; 

sb455w@nih.gov. 

Juan Rivera: Senior Investigator, 

NIAMS, NIH; 301–496–7592; 

riveraj@mail.nih.gov. 

Lisa Begg: Director of Research, 

ORWH, OD, NIH; 301–496–7853; 

beggl@od.nih.gov. 

Dated: May 5, 2010. 

Francis S. Collins, 

Director, National Institutes of Health. 

[FR Doc. 2010–11169 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development Initial 

Review Group; Population Sciences 

Subcommittee. 

Date: June 17–18, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaylord National Hotel & 

Convention Center, 201 Waterford Street, 

National Harbor, MD 20745. 

Contact Person: Carla T. Walls, PhD, 

Scientific Review Officer, Division of 

Scientific Review, National Institute of Child 

Health and Human Development, NIH, 6100 

Executive Blvd., Room 5b01, Bethesda, MD 

20892, (301) 435–6898, wallsc@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos.: 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: April 30, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11073 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the meeting of the 

National Cancer Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4), and 552b(c)(6), Title 5 

U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Advisory Board Ad hoc Subcommittee on 

Experimental Therapeutics. 

Open: June 21, 2010, 6:30 p.m. to 8 p.m. 

Agenda: Discussion on Experimental 

Therapeutics. 

Place: Embassy Suites, Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Dr. Joseph Tomaszewski, 

Executive Secretary, NCAB Ad hoc 

Subcommittee on Experimental 

Therapeutics, National Cancer Institute, 

National Institutes of Health, 31 Center Drive, 

Room 3A44, Bethesda, MD 20892–8345, 

(301) 496–8531. 

Name of Committee: National Cancer 

Advisory Board. 

Open: June 22, 2010, 8 a.m. to 4 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Closed: June 22, 2010, 4 p.m. to 

adjournment. 

Agenda: Review of grant applications. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Name of Committee: National Cancer 

Advisory Board. 

Open: June 23, 2010, 8:30 a.m. to 12 p.m. 

Agenda: Program reports and 

presentations; business of the Board. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, C Wing, 6th 

Floor, Conference Room 10, Bethesda, MD 

20892. 

Contact Person: Dr. Paulette S. Gray, 

Executive Secretary, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, 8th Floor, Room 8001, 

Bethesda, MD 20892–8327, (301) 496–5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 


emcdonald on DSK2BSOYB1PROD with NOTICES
26268 Federal Register / Vol. 75, No. 90 / Tuesday, May 11, 2010 / Notices 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/ncab.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: May 3, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11070 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, ARRA— 

Behavioral Economics C.E.R.—Clinical 

Trials. 

Date: June 3, 2010. 

Time: 2 p.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C218, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Alfonso R. Latoni, PhD., 

Deputy Chief, Scientific Review Branch, 

National Institute on Aging, 7201 Wisconsin 

Avenue, Suite 2C218, Bethesda, MD 20892, 

301–402–7702, Alfonso.Latoni@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research; 

93.701, ARRA Related Biomedical Research 

and Research Support Awards., National 

Institutes of Health, HHS) 

Dated: May 7, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11052 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders B. 

Date: June 17, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Admiral Fell Inn, 888 South 

Broadway, Baltimore, MD 21231. 

Contact Person: William Ernest W. Lyons, 

PhD., Scientific Review Officer, Scientific 

Review Branch, NINDS/NIH/DHHS, 6001 

Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–496–4056. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, Neurological Sciences and 

Disorders A. 

Date: June 23–24, 2010. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Carlyle Suites Hotel, 1731 New 

Hampshire Avenue, NW., Washington, DC 

20009. 

Contact Person: Richard D. Crosland, PhD., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS, Neuroscience Center, 

6001 Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–496–9223. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Initial 

Review Group, NST–2 Subcommittee. 

Date: July 12–13, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Willard InterContinental 

Washington, 1401 Pennsylvania Avenue, 

NW., Washington, DC 20004. 

Contact Person: JoAnn McConnell, PhD., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Research, 

NINDS/NIH/DHHS, Neuroscience Center, 

6001 Executive Blvd., Suite 3208, MSC 9529, 

Bethesda, MD 20892–9529, 301–496–5324, 

mcconnej@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: May 6, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11048 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; 

Cancellation of Meeting 

Notice is hereby given of the 

cancellation of the Center for Scientific 

Review Special Emphasis Panel, May 

25, 2010, 2:30 p.m. to May 25, 2010, 4 

p.m., Courtyard Marriott Tysons Corner, 

1960–A Chain Bridge Road, McLean, 

VA 22102 which was published in the 

Federal Register on April 30, 2010, 75 

FR 22819. 

The meeting was cancelled due to 

administration problems. 

Dated: May 4, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–11046 Filed 5–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

U.S. Customs and Border Protection 

Agency Information Collection 

Activities: Permit To Transfer 

Containers to a Container Station 

AGENCY: U.S. Customs and Border 

Protection, Department of Homeland 

Security. 

ACTION: 60-Day Notice and request for 

comments; Extension of an existing 

collection of information: 1651–0049. 


emcdonald on DSK2BSOYB1PROD with NOTICES